| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |